Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Surgical Infections|May 21, 2019
Comparison of Short-Course and Prolonged Antimicrobial Therapy in the Management of Intra-Abdominal InfectionsKelli Cole, Mina Phlamon, Sarah E Petite
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 29, 2021
Time between diagnosis and achievement of virologic suppression in people living with HIVDanica Joy C Ilagan, Lindsey Eitniear, Kelli Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2014
Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host diseaseAhmad Samer Al-Homsi, Tara S Roy, Kelli Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2015
Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I StudyAhmad-Samer Al-Homsi, Kelli Cole, Marlee Bogema, et al.
Frontiers in Immunology|May 7, 2020
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow TransplantationLouis Williams, Frank Cirrone, Kelli Cole, et al.
Clinical Hematology International|October 1, 2021
Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in AdultsCosmin Tegla, Jun Choi, Maher Abdul-Hay, et al.
Experimental Hematology|December 24, 2016
Ixazomib suppresses human dendritic cell and modulates murine graft-versus-host disease in a schedule-dependent fashionAhmad Samer Al-Homsi, Austin Goodyke, Kelli Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2016
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent AloneAhmad Samer Al-Homsi, Austin Goodyke, Michael McLane, et al.
Clinical Hematology International|October 1, 2021
Human Herpes Virus-6 Encephalitis Following Autologous Blood and Marrow TransplantJacques Mario Azzi, Doyun Park, Maher Abdul-Hay, et al.
Experimental Hematology|May 26, 2016
Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantationAhmad Samer Al-Homsi, Yuxin Feng, Ulrich Duffner, et al.
Pageof 2